Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence.
OBJECTIVE
The purpose of the present review was to assess the quality of evidence in the literature regarding the specific benefits of inspiratory muscle training (IMT) with an emphasis on training intensity and the relationships between changes in inspiratory muscle function and other clinical outcome measures.


METHODS
Articles were found by searching CINAHL, PubMed, Medline via First Search, and ProQuest databases. Articles used in the review were randomized trials of IMT vs. sham IMT or no intervention, published in English in a peer-reviewed journal, included patients with chronic obstructive pulmonary disease (COPD), and specified the intensity of training. The quality of the studies was evaluated by 2 independent reviewers using the methodological rigor scale described by Medlicott and Harris as well as Sackett's levels of evidence. Fifteen articles met the inclusion criteria and were used in this review.


RESULTS
Consistent improvements in maximal inspiratory pressures (ranging from -11 to -30 cm H(2)O) and inspiratory muscle endurance were found. Improvements in dyspnea and health-related quality of life were also observed. Inspiratory muscle training may result in improved exercise tolerance as measured using walking tests. High-intensity IMT resulted in improved training efficiency with respect to inspiratory muscle strength, but evidence of the effect of high-intensity IMT on other clinical outcomes is lacking.


CONCLUSIONS
Despite research spanning decades, there are numerous limitations in the literature regarding IMT. IMT appears to improve dyspnea, waking test distance, and health-related quality of life in individuals with COPD, but it is not clear whether this improvement is mediated through improved inspiratory muscle strength and endurance. This review discussed several considerations critical to the design of future trials.
Shoemaker
Michael J
MJ
Grand Valley State University, Physical Therapy Program, Grand Rapids, MI.
Donker
Sarah
S
Lapoe
Ashley
A
Ann Intern Med. 1989 Jul 15;111(2):117-24
2742247
Am J Respir Crit Care Med. 1996 Jan;153(1):260-5
8542126
Am Rev Respir Dis. 1988 Sep;138(3):689-96
3202422
Am J Respir Crit Care Med. 2000 Jan;161(1):118-23
10619807
Respiration. 2006;73(2):151-6
16155355
Chest. 2005 Nov;128(5):3177-82
16304259
Nurs Res. 1993 Nov-Dec;42(6):356-62
8247819
Eur Respir J Suppl. 1989 Jul;7:587s-591s
2803413
Respir Med. 2008 Dec;102(12):1715-29
18708282
Am J Respir Crit Care Med. 2001 Jun;163(7):1637-41
11401887
Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 2):S1-40
10194189
Aust J Physiother. 2004;50(3):169-80
15482248
Eur Respir J. 2006 Jun;27(6):1119-28
16772388
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
11316667
Thorax. 2008 Sep;63(9):775-7
18390634
Chest. 2002 May;121(5 Suppl):121S-126S
12010839
Respir Med. 2005 Nov;99(11):1440-58
15894478
Chest. 2001 Sep;120(3):748-56
11555505
J Appl Physiol Respir Environ Exerc Physiol. 1983 Jul;55(1 Pt 1):8-15
6411667
J Cardiopulm Rehabil Prev. 2008 Mar-Apr;28(2):128-41
18360190
Am J Respir Crit Care Med. 2002 Dec 1;166(11):1491-7
12406842
J Cardiopulm Rehabil. 2001 Jul-Aug;21(4):231-40
11508185
Eur Respir J. 2002 Sep;20(3):570-6
12358330
Am J Respir Crit Care Med. 1997 Apr;155(4):1278-82
9105067
COPD. 2005 Sep;2(3):319-29
17146997
Eur Respir J. 1998 Jan;11(1):28-33
9543266
J Formos Med Assoc. 2003 Apr;102(4):240-5
12833187
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1459-64
9817693
Chest. 2003 Oct;124(4):1357-64
14555566
Am Rev Respir Dis. 1992 Mar;145(3):533-9
1532118
Am J Respir Crit Care Med. 2003 Jul 1;168(1):10-48
12826594
Chest. 1994 Jul;106(1):110-7
8020255
Respir Med. 2000 Jul;94(7):689-93
10926341
Phys Ther. 2006 Jul;86(7):955-73
16813476
Eur Respir J. 1997 Mar;10(3):537-42
9072981
Thorax. 2006 Jul;61(7):551-2
16807386